CureDuchenne Presentation – The Critical Role of Venture Philanthropy in Developing DMD Therapeutics

Dr. Jak Knowles of CureDuchenne Ventures sheds light on Duchenne Muscular Dystrophy, CureDuchenne’s role in seeking a cure, and its non-dilutive and venture philanthropy funding models supporting R&D.

/0 Comments/by
You might also like
National MS Society Presentation – Accelerating Translational R&D for Multiple Sclerosis
NIBIB Presentation – Funding Opportunities for Medical Device Development
MJFF Presentation – How Venture Philanthropy De-Risks Research in Parkinson’s Disease
LSN Presentation – Fundraising Best Practices
NIAID Presentation – Infectious Disease Product Enabling Opportunities with NIAID
11th Annual Non-Dilutive Funding Summit Keynote Address
Non-Dilutive Funding Mega-Panel: The Relationship Between Industry and Non-Dilutive Sources
R&DMoneyView Unveiling at the 11th Annual Non-Dilutive Funding Summit
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published.